EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023
Allergic rhinitis is a chronic respiratory disease chara...
3.6.2 Limitations Of The Analysis 38
3.6.3 Strengths Of The Analysis 39
4 Appendix 40
4.1 Bibliography 40
4.2 About The Au...
Upcoming SlideShare
Loading in...5
×

Epi cast report allergic rhinitis - epidemiology forecast to 2023

20

Published on

According to GlobalData's epidemiological forecast, the total prevalent cases of allergic rhinitis in the 7MM will increase from 123,273,876 total prevalent cases in 2013 to 125,427,387 total prevalent cases in 2023, at an annual growth rate (AGR) of 0.17% during the forecast period. In 2023, the US will have the highest number of the total prevalent cases of allergic rhinitis with 39,031,365 total prevalent cases, followed by Japan with 36,602,227 total prevalent cases.

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
20
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Epi cast report allergic rhinitis - epidemiology forecast to 2023

  1. 1. EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023 Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and sore throat. Research suggests that a combination of genetic factors such as family history of allergic rhinitis and environmental factors such as exposure to allergens, including smoke, dust, pollen, insects, molds, or animal dander, may increase the risk for developing allergic rhinitis. According to the World Health Organization, an estimated 400 million people worldwide were affected with allergic rhinitis during 1996-2006. According to GlobalData's epidemiological forecast, the total prevalent cases of allergic rhinitis in the 7MM will increase from 123,273,876 total prevalent cases in 2013 to 125,427,387 total prevalent cases in 2023, at an annual growth rate (AGR) of 0.17% during the forecast period. In 2023, the US will have the highest number of the total prevalent cases of allergic rhinitis with 39,031,365 total prevalent cases, followed by Japan with 36,602,227 total prevalent cases. To forecast the total prevalent cases of allergic rhinitis in the 7MM, GlobalData epidemiologists selected nationally representative studies that provided total prevalence of allergic rhinitis using uniform diagnostic criteria based on the self-reported prevalence of allergic rhinitis. The use of studies that provided uniform diagnostic criteria for total prevalence of allergic rhinitis facilitated meaningful comparison of the forecast total prevalent cases of allergic rhinitis across the 7MM. Additionally, GlobalData epidemiologists provide the total prevalent cases of allergic rhinitis segmented by the etiological type of allergic rhinitis (seasonal, perennial, and both), as well as by the severity of allergic rhinitis (mild, moderate, and severe) in these markets. In addition, GlobalData epidemiologists provide the population of allergic rhinitis cases segmented by sensitization to specific allergens in the six major markets (6MM) (France, Germany, Italy, Spain, UK and Japan), which are of utmost importance in the management of the condition. Scope The Allergic Rhinitis EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends of allergic rhinitis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of the total prevalent cases of allergic rhinitis segmented by sex and age (ages =18 years). The allergic rhinitis epidemiology report is written and developed by Mastersand PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM. Reasons to buy Develop business strategies by understanding the trends shaping and driving the global allergic rhinitis market. Quantify patient populations in the global allergic rhinitis market to improve product design, pricing, and launch plans. Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for allergic rhinitis therapeutics in each of the markets covered. table Of Contents 1 Table Of Contents 4 1.1 List Of Tables 6 1.2 List Of Figures 7 2 Introduction 8 2.1 Catalyst 8 2.2 Upcoming Reports 8 3 Epidemiology 9 3.1 Disease Background 9 3.2 Risk Factors And Comorbidities 10 3.2.1 Family History Of Allergic Rhinitis Is A Strong Predictor For Allergic Rhinitis In Children And Adults 11 3.2.2 Exposure To Allergens In The Environment Increases The Risk For Allergic Rhinitis 12 3.2.3 Urban Living Elevates The Risk Of Allergic Rhinitis 13 3.2.4 People With Allergic Rhinitis Suffer From Several Comorbidities 13 3.3 Global And Historical Trends 15 3.3.1 Us 15 3.3.2 5eu 16 3.3.3 Japan 17 3.4 Forecast Methodology 18 3.4.1 Sources Used 20 3.4.2 Sources Not Used 23 3.4.3 Forecast Assumptions And Methods 24 3.5 Epidemiological Forecast Of Allergic Rhinitis (2013-2023) 28 3.5.1 Total Prevalent Cases Of Allergic Rhinitis 28 3.5.2 Age-specific Total Prevalent Cases Of Allergic Rhinitis 29 3.5.3 Sex-specific Total Prevalent Cases Of Allergic Rhinitis 31 3.5.4 Age-standardized Total Prevalence Of Allergic Rhinitis 33 3.5.5 Distribution Of Total Prevalent Cases Of Allergic Rhinitis By Severity 34 3.5.6 Distribution Of Total Prevalent Cases Of Allergic Rhinitis By Type 35 3.5.7 Allergic Rhinitis Total Prevalent Cases Sensitized To Specific Allergens 36 3.6 Discussion 37 3.6.1 Epidemiological Forecast Insight 37 EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023
  2. 2. 3.6.2 Limitations Of The Analysis 38 3.6.3 Strengths Of The Analysis 39 4 Appendix 40 4.1 Bibliography 40 4.2 About The Authors 44 4.2.1 Epidemiologists 44 4.2.2 Reviewers 44 4.2.3 Global Director Of Epidemiology And Health Policy 46 4.2.4 Global Head Of Healthcare 46 4.3 About Globaldata 47 4.4 About Epicast 47 4.5 Disclaimer 48 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

×